栢能集團(01263.HK)2023年總收入至91.67億港元 同比減少14.9%
格隆匯3月14日丨栢能集團(01263.HK)公吿,公司總收入由2022年的10,775.3百萬港元減少1,608.1百萬港元至2023年的9,167.2百萬港元,減幅為14.9%,主要是由於儘管其他個人電腦相關產品及零件分部增幅已抵銷部分跌幅,圖像顯示卡及EMS業務的銷售仍雙雙下跌。年內,業務主要受多個地緣政治及經濟因素導致銷售下跌影響。
公司擁有人應占溢利60.8百萬港元,而2022年則錄得702.5百萬港元。錄得減幅主要是由於即使減少經營費用抵銷部分影響,但毛利仍錄得顯著跌幅所致。董事會建議派付末期股息每股0.2港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.